Chile vs United Arab Emirates: Access to anti-retroviral drugs, male
Chile
73.0%
in 2024
United Arab Emirates
73.0%
in 2024
Chile rank
62nd
United Arab Emirates rank
62nd
Access to anti-retroviral drugs, male over time
- Chile
- United Arab Emirates
How they compare
Chile currently reports 73.0% against 73.0% in United Arab Emirates, a difference of 0.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Chile ahead.
Chile ranks 62nd and United Arab Emirates ranks 62nd of 141 countries.
Chile has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 25.7% | 18.4% | 7.3% | Chile |
| 2010s | 57.0% | 25.4% | 31.6% | Chile |
| 2020s | 76.6% | 71.0% | 5.6% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Chile or United Arab Emirates?
- Chile, at 73.0% against 73.0% in United Arab Emirates as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Chile and United Arab Emirates?
- 0.0%, with Chile ahead.
- How many years of comparable data are there for Chile and United Arab Emirates?
- 25 years are reported by both, from 2000 to 2024.
- How do Chile and United Arab Emirates rank globally for access to anti-retroviral drugs, male?
- Chile ranks 62nd and United Arab Emirates ranks 62nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.